The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemotherapy (NAC) followed by total mesorectal excision (TME) and adjuvant chemotherapy versus TME followed by adjuvant chemotherapy in very low-lying clinical (c) T3 rectal cancer (NAIR): A multicenter, randomized, open-label, phase 2/3 trial.
 
Yuichiro Tsukada
No Relationships to Disclose
 
Yoshiyuki Kawashima
No Relationships to Disclose
 
Fumihiko Fujita
No Relationships to Disclose
 
Keiji Koda
No Relationships to Disclose
 
Masayuki Ohue
Speakers' Bureau - Chugai Pharma
Research Funding - Taiho Pharmaceutical
 
Eiji Shinto
No Relationships to Disclose
 
Akihiko Murata
No Relationships to Disclose
 
Yoshikazu Koide
No Relationships to Disclose
 
Yuji Nishizawa
No Relationships to Disclose
 
Hideaki Bando
Honoraria - Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Taiho Pharmaceutical
 
Motoko Suzuki
No Relationships to Disclose
 
Toshihiro Misumi
No Relationships to Disclose
 
Takayuki Yoshino
Honoraria - Bayer Yakuhin; Chugai Pharma; Merck; MSD K.K.; Ono Pharmaceutical
Research Funding - Amgen (Inst); Chugai Pharma (Inst); DAIICHI SANKYO COMPANY, LIMITED (Inst); Genomedia (Inst); MSD (Inst); Nippon Boehringer Ingelheim (Inst); Ono Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Sysmex (Inst); Taiho Pharmaceutical (Inst)
 
Norio Saito
No Relationships to Disclose
 
Masaaki Ito
Employment - Asahi Intecc; Jmees Inc.
Stock and Other Ownership Interests - Jmees Inc.
Honoraria - Applied Medical Japan; Bayer Yakuhin; Covidien; Fujifilm; Johnson & Johnson; Kaken Pharmaceutical; Nippon Zoki Pharmaceutical Co.; Olympus
Consulting or Advisory Role - Asahi Intecc
Research Funding - A-Traction; Astellas Pharma; Covidien; EBM; Fujifilm; Fujita Medical Instruments; Indivumed; Johnson & Johnson; Kawasumi Laboratories; Muranaka Medical Instruments; Olympus; Sumitomo Chemical
Patents, Royalties, Other Intellectual Property - BMG; EBM; Fujita Medical Instruments; Kotobuki Medical; Muranaka Medical Instrument; NITION; Olympus; Sumitomo Chemical